Theorem Clinical Research

Global News

CORD:USE, Tianhe Stem Cell Biotechnologies partner

Thursday, October 2, 2014 02:20 PM

CORD:USE Cord Blood Bank, headquartered in Orlando, Fla., an operator of both public and family cord blood banks, has entered into an agreement with Illinois–based Tianhe Stem Cell Biotechnologies, which has licensed a series of patented technologies for the isolation of human cord blood-derived multipotent stem cells for possible clinical applications.

More... »


NCI co-funding Pharmatech Just-In-Time expansion

Thursday, October 2, 2014 02:13 PM

The National Cancer Institute (NCI) is co-funding Denver, Colo.-based CRO Pharmatech’s development of AccessPPM and expansion of its Just-In-Time enrollment programs.

More... »


NIBSC signs agreement with UCL

Thursday, October 2, 2014 02:09 PM

A memorandum of understanding has been signed between the National Institute for Biological Standards and Control and University College London (UCL). The memorandum states that both parties should share common goals to help safeguard and enhance public health in the U.K. and elsewhere. Best available science should be applied to the international harmonization of standards for characterization, production and distribution, and the availability of cell lines and other key materials of appropriate quality for research and clinical use should be facilitated.

More... »

Noven receives FDA new indication approval for Minivelle

Thursday, October 2, 2014 02:01 PM

Noven Pharmaceuticals has announced that the FDA has approved a new indication with a new dose of Minivelle (estradiol transdermal system) for the prevention of postmenopausal osteoporosis. The FDA initially approved Minivelle in October 2012 to treat moderate to severe vasomotor symptoms (VMS) due to menopause, commonly known as hot flashes. With this new approval, women who are using Minivelle to treat their VMS symptoms have the benefit of also helping to prevent osteoporosis.

More... »

BioClinica Compass wins technology innovation award

Thursday, October 2, 2014 01:32 PM

BioClinica, a provider of outsourced clinical trial services and eClinical Solutions, has announced that its Compass technology, a risk-based monitoring solution that improves overall quality in clinical trials, has won the inaugural Society for Clinical Data Management (SCDM) NextGen Technology Innovation (TIA) Award, presented as part of SCDM's 2014 annual conference.

More... »

Zynerba Pharmaceuticals expands management team

Thursday, October 2, 2014 01:30 PM

Zynerba Pharmaceuticals, a specialty pharmaceutical company dedicated to the development of innovative transdermal cannabinoid treatments, has named three seasoned pharmaceutical executives to its management team. Donna Gutterman, PharmD, is a consultant who will be vice president, medical affairs; Carol O'Neill will be vice president, development; and Suzanne Hanlon will be general counsel and vice president, human resources.

More... »

Mast Therapeutics appoints Edwin L. Parsley chief medical officer

Thursday, October 2, 2014 01:21 PM

Mast Therapeutics, a clinical-stage biopharmaceutical company, has announced that Edwin L. Parsley, D.O., has joined the company as its chief medical officer and senior vice president.

More... »

Amgen reports positive results of two phase III studies of evolocumab

Thursday, October 2, 2014 12:46 PM

Amgen has announced data from two phase III studies, RUTHERFORD-2 and TESLA, that showed treatment with evolocumab, a novel investigational low-density lipoprotein cholesterol (LDL-C)-lowering medication, resulted in a statistically significant reduction in LDL-C compared to placebo in patients with different types of familial hypercholesterolemia (FH). FH is an inherited condition caused by a gene mutation, which leads to high levels of LDL-C, or "bad" cholesterol, and premature cardiovascular disease.

More... »

CMS makes first wave of open payments data public

Thursday, October 2, 2014 08:27 AM

Centers for Medicare & Medicaid Services (CMS), as part of its ongoing effort to increase transparency and accountability in healthcare, this week released the first round of Open Payments data to help consumers understand the financial relationships between the healthcare industry and physicians and teaching hospitals.

More... »

Baxter to form new innovation and R&D center for biopharmaceuticals

Wednesday, October 1, 2014 01:26 PM

Baxter International plans to form a new global innovation and R&D center in Cambridge, Mass., for Baxter's biopharmaceuticals business, which is expected to become a separate, independent global company known as Baxalta in mid-2015.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

October 20

Toronto Star, with FDA data, exposes weaknesses in Health Canada's clinical trial, inspection oversight

Crowdsourcing effort aims to fund updated online social media guide for sponsor interaction with patients

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

September

Today's fastest, most economical sponsors
Standout sponsors reveal how they shorten regulatory, clinical cycle times

From the trenches: Sites' eye view of state of the industry
CW’s first site focus groups uncover frustration with 'progress,' but a passion for their mission

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

August

Reality of costs and impact rain on Sunshine Act
Concerns mount over compliance burden on CROs, sponsors, unanticipated consequences for research

Cloud computing expanding into all areas of clinical trial conduct
Benefits outweigh the complexities, challenges of finding right vendors

Already a subscriber?
Log in to your digital subscription.

Purchase the August issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs